| NDC Code | 39822-4025-2 |
|---|
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (39822-4025-2) > 10 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 39822-4025 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Magnesium Sulfate |
|---|
| Non-Proprietary Name | Magnesium Sulfate Heptahydrate |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAMUSCULAR; INTRAVENOUS |
|---|
| Start Marketing Date | 20140223 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA206039 |
|---|
| Manufacturer | X-GEN Pharmaceuticals, Inc. |
|---|
| Substance Name | MAGNESIUM SULFATE HEPTAHYDRATE |
|---|
| Strength | 500 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] |
|---|